Literature DB >> 23643073

Age at onset and clinical correlates in body dysmorphic disorder.

Andri S Bjornsson1, Elizabeth R Didie, Jon E Grant, William Menard, Emily Stalker, Katharine A Phillips.   

Abstract

OBJECTIVE: Age at onset is an important clinical feature of all disorders. However, no prior studies have focused on this important construct in body dysmorphic disorder (BDD). In addition, across a number of psychiatric disorders, early age at disorder onset is associated with greater illness severity and greater comorbidity with other disorders. However, clinical correlates of age at onset have not been previously studied in BDD.
METHODS: Age at onset and other variables of interest were assessed in two samples of adults with DSM-IV BDD; sample 1 consisted of 184 adult participants in a study of the course of BDD, and sample 2 consisted of 244 adults seeking consultation or treatment for BDD. Reliable and valid measures were used. Subjects with early-onset BDD (age 17 or younger) were compared to those with late-onset BDD.
RESULTS: BDD had a mean age at onset of 16.7 (SD=7.3) in sample 1 and 16.7 (SD=7.2) in sample 2. 66.3% of subjects in sample 1 and 67.2% in sample 2 had BDD onset before age 18. A higher proportion of females had early-onset BDD in sample 1 but not in sample 2. On one of three measures in sample 1, those with early-onset BDD currently had more severe BDD symptoms. Individuals with early-onset BDD were more likely to have attempted suicide in both samples and to have attempted suicide due to BDD in sample 2. Early age at BDD onset was associated with a history of physical violence due to BDD and psychiatric hospitalization in sample 2. Those with early-onset BDD were more likely to report a gradual onset of BDD than those with late-onset in both samples. Participants with early-onset BDD had a greater number of lifetime comorbid disorders on both Axis I and Axis II in sample 1 but not in sample 2. More specifically, those with early-onset BDD were more likely to have a lifetime eating disorder (anorexia nervosa or bulimia nervosa) in both samples, a lifetime substance use disorder (both alcohol and non-alcohol) and borderline personality disorder in sample 1, and a lifetime anxiety disorder and social phobia in sample 2.
CONCLUSIONS: BDD usually began during childhood or adolescence. Early onset was associated with gradual onset, a lifetime history of attempted suicide, and greater comorbidity in both samples. Other clinical features reflecting greater morbidity were also more common in the early-onset group, although these findings were not consistent across the two samples.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23643073      PMCID: PMC3779493          DOI: 10.1016/j.comppsych.2013.03.019

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  65 in total

1.  Development of the body dysmorphic disorder examination.

Authors:  J C Rosen; J Reiter
Journal:  Behav Res Ther       Date:  1996-09

2.  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.

Authors:  J B Williams; M Gibbon; M B First; R L Spitzer; M Davies; J Borus; M J Howes; J Kane; H G Pope; B Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1992-08

3.  A 12-month follow-up study of the course of body dysmorphic disorder.

Authors:  Katharine A Phillips; Maria E Pagano; William Menard; Robert L Stout
Journal:  Am J Psychiatry       Date:  2006-05       Impact factor: 18.112

4.  Association between age at onset and clinical features of schizophrenia: the Northern Finland 1966 birth cohort study.

Authors:  Suvi Luoma; Helinä Hakko; Taru Ollinen; Marjo-Riitta Järvelin; Sari Lindeman
Journal:  Eur Psychiatry       Date:  2008-05-02       Impact factor: 5.361

5.  Efficacy and safety of fluvoxamine in body dysmorphic disorder.

Authors:  K A Phillips; M M Dwight; S L McElroy
Journal:  J Clin Psychiatry       Date:  1998-04       Impact factor: 4.384

6.  A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.

Authors:  Katharine A Phillips; Ralph S Albertini; Steven A Rasmussen
Journal:  Arch Gen Psychiatry       Date:  2002-04

7.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure.

Authors:  J Endicott; J Nee; W Harrison; R Blumenthal
Journal:  Psychopharmacol Bull       Date:  1993

8.  Early age at onset of bipolar disorder is associated with more severe clinical features but delayed treatment seeking.

Authors:  Kirsi Suominen; Outi Mantere; Hanna Valtonen; Petri Arvilommi; Sami Leppämäki; Tiina Paunio; Erkki Isometsä
Journal:  Bipolar Disord       Date:  2007-11       Impact factor: 6.744

9.  The Modified Hamilton Rating Scale for Depression: reliability and validity.

Authors:  I W Miller; S Bishop; W H Norman; H Maddever
Journal:  Psychiatry Res       Date:  1985-02       Impact factor: 3.222

10.  Patterns of axis II comorbidity in early-onset versus late-onset panic disorder in Japan.

Authors:  Toshiya Iketani; Nobuo Kiriike; Murray B Stein; Kouji Nagao; Naomitsu Minamikawa; Atsushi Shidao; Hidehiro Fukuhara
Journal:  Compr Psychiatry       Date:  2004 Mar-Apr       Impact factor: 3.735

View more
  20 in total

1.  Young Adolescents' Body Dysmorphic Symptoms: Associations with Same- and Cross-Sex Peer Teasing via Appearance-based Rejection Sensitivity.

Authors:  Haley J Webb; Melanie J Zimmer-Gembeck; Shawna Mastro; Lara J Farrell; Allison M Waters; Cassie H Lavell
Journal:  J Abnorm Child Psychol       Date:  2015-08

Review 2.  Suicidality in Subjects With Anxiety or Obsessive-Compulsive and Related Disorders: Recent Advances.

Authors:  Diego De La Vega; Lucas Giner; Philippe Courtet
Journal:  Curr Psychiatry Rep       Date:  2018-03-28       Impact factor: 5.285

3.  The Multidimensional Youth Body Dysmorphic Inventory: Development and Preliminary Validation.

Authors:  Carly Roberts; Melanie J Zimmer-Gembeck; Lara J Farrell
Journal:  Child Psychiatry Hum Dev       Date:  2019-12

4.  Body Dysmorphic Disorder: Clinical Overview and Relationship to Obsessive-Compulsive Disorder.

Authors:  Katharine A Phillips; Megan M Kelly
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-11-05

5.  Telephone-Administered Cognitive Behavioral Therapy for Body Dysmorphic Disorder: Case Series.

Authors:  Marie Drüge; Tanja Roth; Birgit Watzke
Journal:  Int J Environ Res Public Health       Date:  2022-06-16       Impact factor: 4.614

6.  Validation of Spanish Language Evaluation Instruments for Body Dysmorphic Disorder and the Dysmorphic Concern Construct.

Authors:  Cristina Senín-Calderón; María Valdés-Díaz; Ma M Benítez-Hernández; Ma C Núñez-Gaitán; Salvador Perona-Garcelán; Rafael Martínez-Cervantes; Juan F Rodríguez-Testal
Journal:  Front Psychol       Date:  2017-06-30

7.  Self-Perception and Self-Acceptance Are Related to Unhealthy Weight Control Behaviors in Catalan Adolescents: A Cross-Sectional Study.

Authors:  Mercè Pollina-Pocallet; Eva Artigues-Barberà; Glòria Tort-Nasarre; Joaquim Sol; Laura Azlor; Quintí Foguet-Boreu; Marta Ortega-Bravo
Journal:  Int J Environ Res Public Health       Date:  2021-05-07       Impact factor: 3.390

8.  Body dysmorphic disorder and self-esteem: a meta-analysis.

Authors:  Nora Kuck; Lara Cafitz; Paul-Christian Bürkner; Laura Hoppen; Sabine Wilhelm; Ulrike Buhlmann
Journal:  BMC Psychiatry       Date:  2021-06-15       Impact factor: 3.630

9.  The association between body dysmorphic symptoms and suicidality among adolescents and young adults: a genetically informative study.

Authors:  Georgina Krebs; Lorena Fernández de la Cruz; Frühling V Rijsdijk; Daniel Rautio; Jesper Enander; Christian Rück; Paul Lichtenstein; Sebastian Lundström; Henrik Larsson; Thalia C Eley; David Mataix-Cols
Journal:  Psychol Med       Date:  2020-09-17       Impact factor: 10.592

Review 10.  Recent advances in understanding and managing body dysmorphic disorder.

Authors:  Georgina Krebs; Lorena Fernández de la Cruz; David Mataix-Cols
Journal:  Evid Based Ment Health       Date:  2017-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.